Microrna Biomarkers on Day of Injury Among Patients with Post Concussive Symptoms at 28-Days: A Prospective Cohort Study.
Biswadev MitraBrendan MajorJonathan ReyesNanda SurendranJesse BainLauren GieslerWilliam T O'BrienEdmond SorichCatherine WillmottSandy R ShultzTerence J O'BrienJeffrey V RosenfeldStuart J McDonaldPublished in: MicroRNA (Shariqah, United Arab Emirates) (2024)
Acute plasma miR-223-3p levels appear to detect patients who later have persistent symptoms after mTBI. The results demonstrate the potential utility for such biomarkers to assist in decisions towards early referral for therapy after mTBI.